In fact, Andrlová et al. [25] described that biglycan is able to modulate ECM organization/structure by up-regulating the expression of the integrin-β1 adhesion molecule, which, in turn, increases the matrix stiffness and modulates the tumor-related survival. This evidence concerns the gene BGN and neoplasm.